CLAREMON, David A.,DONG, Chengguo,FAN, Yi,LEFTHERIS, Katerina,LOTESTA, Stephen D.,SINGH, Suresh B.,TICE, Colin M.,ZHAO, Wei,ZHENG, Yajun,ZHUANG, Linghang
申请号:
ES15750548
公开号:
ES2768685T3
申请日:
2015.08.04
申请国别(地区):
ES
年份:
2020
代理人:
摘要:
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are liver X receptor modulators, and which are useful in the treatment of diseases and disorders associated with the liver X receptor. Also provided are the compounds of Formula (I) and pharmaceutical compositions thereof for treating atherosclerosis, cardiovascular disease, Alzheimer's disease, dermatitis, dyslipidemia, cancer and other diseases or disorders.